Remón-Ruiz, PabloVenegas-Moreno, EvaDios-Fuentes, ElenaCanelo Moreno, Juan ManuelFernández Peña, IgnacioAlonso García, MiriamSoto Moreno, Alfonso Manuel2022-09-202022-09-202021Remón-Ruiz, P., Venegas-Moreno, E., Dios-Fuentes, E., Canelo Moreno, J.M., Fernández Peña, I., Alonso García, M. y Soto Moreno, A.M. (2021). A silent corticotroph pituitary carcinoma: lessons from an exceptional case. Frontiers in Endocrinology, 12, 1-9.1664-2392https://hdl.handle.net/11441/137243Nowadays, neither imaging nor pathology evaluation can accurately predict the aggressiveness or treatment resistance of pituitary tumors at diagnosis. However, histological examination can provide useful information that might alert clinicians about the nature of pituitary tumors. Here, we describe our experience with a silent corticothoph tumor with unusual pathology, aggressive local invasion and metastatic dissemination during follow-up. We present a 61-year-old man with third cranial nerve palsy at presentation due to invasive pituitary tumor. Subtotal surgical approach was performed with a diagnosis of silent corticotroph tumor but with unusual histological features (nuclear atypia, frequent multinucleation and mitotic figures, and Ki-67 labeling index up to 70%). After a rapid regrowth, a second surgical intervention achieved successful debulking. Temozolomide treatment followed by stereotactic fractionated radiotherapy associated with temozolomide successfully managed the primary tumor. However, sacral metástasis showed up 6 months after radiotherapy treatment. Due to aggressive distant behavior, a carboplatine-etoposide scheme was decided but the patient died of urinary sepsis 31 months after the first symptoms. Our case report shows how the presentation of a pituitary tumor with aggressive features should raise a suspicion of malignancy and theneed of follow up by multidisciplinary team with experience in its management. Metastases may occur even if the primary tumor is well controlled.application/pdf9 p.engAttribution-NonCommercial-NoDerivatives 4.0 Internacionalhttp://creativecommons.org/licenses/by-nc-nd/4.0/Pituitary tumorSilent corticothoph tumorPituitary carcinomaRadiotherapyA silent corticotroph pituitary carcinoma: lessons from an exceptional caseinfo:eu-repo/semantics/articleinfo:eu-repo/semantics/openAccesshttps://doi.org/10.3389/fendo.2021.784889